LONA
LeonaBio, Inc.
Latest Form 4:Sale$5KbyRenninger Robert (CHIEF FINANCIAL OFFICER) · filed Mar 5, 2026
LeonaBio, Inc. (LONA) has 5 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Mar 5, 2026.
- Industry:Biotechnology
- CEO:Mark J. Litton
- Employees:19
- HQ:Bothell, WA, US
- IPO:2020-09-18
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$56K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Related companies
LeonaBio, Inc. is in the Healthcare sector.